Manorama Industries (541974) Q4 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 25/26 earnings summary
15 May, 2026Executive summary
Achieved FY 2026 standalone revenue of INR 1,358 crores, up 76.1% year-over-year, driven by strong demand in food and cosmetics sectors and expanded value-added product mix.
EBITDA for FY 2026 was INR 367.7 crores (27.1% margin), up 92.5% YoY, with PAT at INR 233.2 crores (17.2% margin), reflecting strong operational leverage and cost control.
Q4 FY 2026 standalone revenue was INR 382.3 crores, EBITDA INR 102.9 crores (26.9% margin), PAT INR 59.5 crores (15.6% margin).
Final dividend of INR 0.80 per share (40% of face value) announced for FY 2026.
Statutory auditors issued an unmodified opinion on both standalone and consolidated results.
Financial highlights
Operating cash flow for FY 2026 was INR 259.4 crores; working capital cycle improved to 125 days.
Net debt-to-equity ratio at 0.38:1 as of March 31, 2026.
Volume growth for FY 2026 was 80%-90%, with 5%-10% price growth.
Gross margin for FY 2026 was 45.28%, with EBITDA margin at 27.1%.
Diluted EPS for FY 2026 was INR 39.05, up 108.5% YoY.
Outlook and guidance
FY 2027 expected to be a strong growth year, driven by capacity expansion, improved product mix, and international expansion.
Targeting 25%-30% annual revenue growth for the next 1-2 years.
EBITDA margin guidance maintained at 25%-27% on a yearly basis.
Capacity utilization targeted at 85%-90% of 52,000 tons in FY 2027.
Long-term revenue target of over INR 3,500 crores by FY 2030 remains on track.
Latest events from Manorama Industries
- Strong Q2/H1 growth and exports support phased expansion despite margin and cash-flow pressures.541974
Q2 26/27 - Manufacturing growth and capacity investment offset the exit from trading.541974
Q4 18/19 - FY23 growth accelerated as capacity expanded, despite input-cost and execution pressures.541974
Q4 22/23 - Revenue rose 37.8% and PAT 65.6% as expansion targets global specialty-fat demand.541974
Q4 21/22 - FY20 sales rose 84% as a new plant expanded capacity amid pandemic disruption.541974
Q4 19/20 - Revenue advanced, but pandemic pressure cut profit as capacity expansion continued.541974
Q4 20/21 - Q1 FY27 revenue and profit surged, supported by global expansion, capex, and strong margins.541974
Q1 26/27 - Record Q3 FY25 revenue and profit, strong margins, and global expansion with new subsidiaries.541974
Q3 24/25 - H1 FY26 revenue and profit surged YoY, margins remained strong, and FY26 guidance was upgraded.541974
Q2 25/26